The next 12 months will be important for the drugmaker.

Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Click for ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

-VX-150 was generally well tolerated and showed statistically significant relief of acute pain compared to placebo; study included an active reference arm of the opioid pain medicine ...

It has been about a month since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 15.8% in that time frame, outperforming the S&P 500. Will the recent positive trend ...